More News
-
-
Continuously Promoting Innovation and Internationalization, Fosun Pharma Presents at 2022 BIO International Convention
2022-06-25(16 June 2022, Shanghai, China) 16 June 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or “the Group”; Stock Code: 600196.SH, 02196.HK), a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China, announced that Fosun Pharma presents a corporate overview at the BIO International Convent
-
-
Fosun Pharma Gains BioNJ Award for Self-developed COVID-19 RT-PCR Detection Kit
2022-06-24(21 June 2022, Shanghai, China) During the BioNJ's 29th Annual Dinner Meeting & Innovation Celebration earlier this month, Fosun Pharma was awarded the Heart of BioNJ with the COVID-19 RT-PCR Detection Kit which was independently developed by its subsidiary company Fosun Diagnostics. The organizer BioNJ said in the award review that the awards were presented to BioNJ member
-
-
S&P Global Rating: Fosun International has flexibility to replenish cash and has adequate resources to manage debt maturities
2022-06-24(24 June 2022) Fosun International Limited (HKEX stock code: 00656, “Fosun International”) said S&P Global Rating has published a report yesterday, stating that Fosun has adequate resources to meet its upcoming debt maturities over the next six to 12 months.S&P Global Rating said in yesterday’s report that it believed the company could rely on asset monetization and s
-
-
Fosun International’s FTSE Russell ESG Rating Upgraded and Becomes First-time Constituent of FTSE4Good Index Series
2022-06-23(23 June, 2022, Hong Kong) The world's leading index company, FTSE Russell, recently announced the latest ESG (Environmental, Social and Governance) rating results of Fosun International Limited (HKEX stock code: 00656) (“Fosun International”). Fosun International's FTSE Russell ESG rating has improved for two consecutive years, outperforming the in
-
-
Morgan Stanley Sees Fosun International (0656.HK) as Cash-rich and Reiterates OVERWEIGHT Rating
2022-06-23(23 June 2022) Morgan Stanley has recently released a research report about Fosun International to reiterate its OVERWEIGHT Rating. An analyst who is a key opinion leader (KOL) has made an in-depth analysis on Bloomberg terminal about Fosun International after the research house has released the report.The following is the article extracted from the Bloomberg terminal post:Morgan Stanley just rel